Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
08/1995
08/17/1995WO1995021917A1 Mammalian cell cycle protein
08/17/1995WO1995021868A1 Monoclonal antibodies specific to vegf receptors and uses thereof
08/17/1995WO1995021612A2 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
08/17/1995WO1995021609A1 Treatment of normotensive glaucoma with angiotensin ii antagonists
08/17/1995WO1995021608A1 Use of insulin sensitisers for treating renal diseases
08/17/1995CA2185683A1 Monoclonal antibodies specific to vegf receptors and uses thereof
08/17/1995CA2183254A1 Mammalian cell cycle protein
08/17/1995CA2182986A1 Use of insulin sensitisers for treating renal diseases
08/17/1995CA2182680A1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
08/17/1995CA2181461A1 Treatment of normotensive glaucoma with angiotensin ii antagonists
08/16/1995EP0667165A1 Therapeutic compositions containing monoclonal antibodies specific to human epidermal growth factor receptor
08/16/1995EP0666906A1 Cho cells expressing human endothelin receptors
08/16/1995EP0666744A1 Use of bhap compounds in combination with other non-nucleoside reverse transcriptase inhibitors for the treatment of hiv infection
08/16/1995EP0666741A1 Dithiocarbamates for the treatment of atherosclerosis and other cardiovascular and inflammatory diseases
08/16/1995CN1106701A Pharmaceutical composition
08/16/1995CN1106659A Preparation for epidermis and process for its preparation
08/15/1995US5442053 Salts and mixtures of hyaluronic acid with pharmaceutically active substances, pharmaceutical compositions containing the same and methods for administration of such compositions
08/15/1995CA1336680C Method and compositions for the treatment and prevention of septic shock
08/15/1995CA1336678C Prophylaxis and treatment of nervous system diseases with melanin
08/11/1995CA2142142A1 Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract
08/10/1995WO1995021245A1 Nucleic acid encoding neuropeptide y/peptide yy (y2) receptors and uses thereof
08/10/1995WO1995020980A1 Method for increasing bioavailability of oral pharmaceutical compositions
08/10/1995WO1995020979A1 Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis
08/10/1995WO1995020977A1 Co-administration of interleukin-3 mutant polypeptides with csf's for multi-lineage hematopoietic cell production
08/10/1995WO1995020971A1 Therapeutic composition for replacing and/or supplementing body fluids
08/10/1995WO1995020969A1 Method for preventing keratocyte loss
08/10/1995WO1995017899A3 Mixtures of dideoxy-nucleosides and hydroxycarbamide for inhibiting retroviral spread
08/10/1995CA2182731A1 Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis
08/10/1995CA2182474A1 Co-administration of interleukin-3 mutant polypeptides with csf's for multi-lineage hematopoietic cell production
08/10/1995CA2177175A1 Method for increasing bioavailability of oral pharmaceutical compositions
08/10/1995CA2159706A1 Method for preventing keratocyte loss
08/10/1995CA2159217A1 Nucleic acid encoding neuropeptide y/peptide yy (y2) receptors and uses thereof
08/09/1995EP0665749A1 Method and composition for the treatment of parkinson's disease
08/09/1995EP0665739A1 Morphogen-induced periodontal tissue regeneration
08/09/1995EP0665729A1 Biocompatible polymers containing diagnostic or therapeutic moieties
08/09/1995EP0403631B1 Method of making high density solder bumps and a substrate socket for high density solder bumps
08/09/1995CN1106405A Trisubstituted pyrimido |5,4-d¨ pyrimidines for modulating
08/09/1995CN1106296A Nutritional Supplement
08/08/1995US5439935 Topical application of mixtures containing a glucosidase and a protease, separately or together, for treatment of dry skin
08/08/1995US5439924 Systemic control of parasites
08/08/1995US5439913 Contraception method using competitive progesterone antagonists and novel compounds useful therein
08/08/1995US5438954 Method and apparatus for early embryonic in ovo injection
08/03/1995WO1995020567A1 Codrugs as a method of controlled drug delivery
08/03/1995WO1995020403A1 Aqueous topical compositions
08/03/1995WO1995020402A1 Antioxidants and intracellular glutathione raising agents for therapeutic treatments
08/03/1995WO1995020394A1 Oral dosage form containing colestipol as a carrier and acidic active substances and a process for producing the same
08/03/1995WO1995020389A1 Benzoxazinones as inhibitors of hiv reverse transcriptase
08/03/1995WO1995020385A1 Inhibition of arthritis by l-type calcium channel antagonists
08/03/1995WO1995020384A1 Pharmaceutical compositions containing hiv protease inhibitors
08/03/1995WO1995020320A1 Self-assembling multimeric nucleic acid constructs
08/03/1995DE4402379A1 Orale Arzneiform mit sauren Wirkstoffen und Verfahren zu ihrer Herstellung Oral dosage form having acidic active ingredients, and processes for their preparation
08/03/1995CA2182489A1 Antioxidants and intracellular glutathione raising agents for therapeutic treatments
08/03/1995CA2182114A1 Inhibition of arthritis by l-type calcium channel antagonists
08/02/1995EP0665016A1 Heart function restorative
08/02/1995CN1105855A Formulation comprising antibacterial substance and antiulcer substance
08/01/1995US5438055 Antiarrhythmic benzodiazepines
08/01/1995US5437872 Pharmaceutical compositions and a device for administering the same
08/01/1995US5437865 Isolated sialylated glycoprotein endosialin, which is expressed by tumor associated vascular endothelium
08/01/1995CA2141231A1 6-azaindole thromboxane synthase inhibitors
08/01/1995CA1336501C Method of preventing or reducing venous thrombosis using a thromboxane a- receptor antagonist in conjunction with heparin and combination
08/01/1995CA1336497C Immunoconjugates for cancer diagnosis and therapy
08/01/1995CA1336496C Immunoconjugates joined by thioether bonds having reduced toxicity and improved selectivity
08/01/1995CA1336490C Pharmacological treatment of ocular development
08/01/1995CA1336488C Dosage form having reduced abuse potential
07/1995
07/27/1995WO1995019965A1 Synthetic matrix metalloprotease inhibitors and uses thereof
07/27/1995WO1995019964A1 Ep2-receptor agonists as agents for lowering intraocular pressure
07/27/1995WO1995019784A1 Human therapeutic uses of bpi protein products
07/27/1995WO1995019771A1 Indole diterpene alkaloid compounds
07/27/1995WO1995019764A1 Cis-hydroxyproline analogs for eye treatment
07/27/1995WO1995019706A1 Inhibitors of fatty acid synthesis as antimicrobial agents
07/27/1995CA2181816A1 Human therapeutic uses of bpi protein products
07/27/1995CA2181788A1 Cis-hydroxyproline analogs for eye treatment
07/27/1995CA2181371A1 Indole diterpene alkaloid compounds
07/27/1995CA2181031A1 Inhibitors of fatty acid synthesis as antimicrobial agents
07/27/1995CA2158760A1 Synthetic matrix metalloprotease inhibitors and uses thereof
07/26/1995EP0664119A2 Tape transdermal use easily detachable from the skin
07/26/1995EP0664117A1 Liposome solutions
07/26/1995EP0663823A1 Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors
07/26/1995CA2140701A1 Liposome solutions
07/25/1995US5436337 Anticarcinogenic agents
07/25/1995US5436258 Prevention of bone resorption
07/25/1995US5436253 Pyridonecarboxylic acid derivatives and mycotic infections
07/25/1995US5436243 Aminoanthraquinone derivatives to combat multidrug resistance
07/25/1995EP0675689A4 Medical foods for the nutritional support of child/adult metabolic diseases.
07/25/1995CA1336436C Gamma aminobutyric acid agonists and their use in the treatment of depression and senile dementia and other forms of memory impairment
07/25/1995CA1336410C Products containing a calcium antagonist and a lipid-lowering agent
07/25/1995CA1336398C Method for reducing side effects of cancer therapy
07/25/1995CA1336397C Methyl cellulose pharmaceutical composition
07/20/1995WO1995019436A1 Mammalian monocyte chemoattractant protein receptors
07/20/1995WO1995019183A1 Cd44 expression in smooth muscle cells
07/20/1995WO1995019181A1 A METHOD OF TREATMENT OF PARASITIC INFECTION USING IgE ANTAGONISTS
07/20/1995WO1995019180A1 Anti-gram-positive bacterial methods and materials
07/20/1995WO1995019179A1 Anti-fungal methods and materials
07/20/1995WO1995019177A1 Vanadate compounds for the treatment of proliferative disorders, metastases and drug resistant tumors
07/20/1995WO1995019169A2 Treatment of platelet derived growth factor related disorders such as cancer using inhibitors of platelet derived growth factor receptor
07/20/1995WO1995019166A1 A method for sustained and extended corneal analgesia
07/20/1995DE4432262A1 Combination prepn. for treatment of digestive tract disorders
07/20/1995CA2181444A1 Vanadate compounds for the treatment of proliferative disorders, metastases and drug resistant tumors
07/20/1995CA2179391A1 Cd44 expression in smooth muscle cells
07/19/1995EP0663014A1 Dna encoding human alpha 1 adrenergic receptors and uses thereof
1 ... 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 ... 1151